APA (7th ed.) Citation

Girma Tekle Gebremariam, Atalay Mulu Fentie, Kebede Beyene, Beate Sander, & Gebremedhin Beedemariam Gebretekle. (2022). Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: A systematic review. BMC.

Chicago Style (17th ed.) Citation

Girma Tekle Gebremariam, Atalay Mulu Fentie, Kebede Beyene, Beate Sander, and Gebremedhin Beedemariam Gebretekle. Cost-effectiveness of Pegfilgrastim Versus Filgrastim for Prevention of Chemotherapy-induced Febrile Neutropenia in Patients with Lymphoma: A Systematic Review. BMC, 2022.

MLA (9th ed.) Citation

Girma Tekle Gebremariam, et al. Cost-effectiveness of Pegfilgrastim Versus Filgrastim for Prevention of Chemotherapy-induced Febrile Neutropenia in Patients with Lymphoma: A Systematic Review. BMC, 2022.